Gilead Sciences (GILD) insider files to sell 3,000 shares via Rule 144

Rhea-AI Filing Summary

GILD insider Andrew Dickinson has filed a Form 144 to potentially sell 3,000 shares of common stock. The planned sale is to be executed through Morgan Stanley Smith Barney on NASDAQ around February 17, 2026, with an indicated aggregate market value of $463,290.

The 3,000 shares were acquired as performance shares from the issuer on January 24, 2023. Over the past three months, Dickinson has already sold 3,000 common shares on December 15, 2025 for $366,000 and another 3,000 shares on January 15, 2026 for $372,930.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	463290.00	1240679623	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/24/2023	Performance Shares	ISSUER			3000	01/24/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	01/15/2026	3000	372930.00
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	12/15/2025	3000	366000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Form 144 filing for GILD disclose?

The filing discloses that Andrew Dickinson plans to sell 3,000 GILD common shares under Rule 144. The proposed sale, through Morgan Stanley Smith Barney on NASDAQ, carries an indicated aggregate market value of $463,290 with an approximate sale date of February 17, 2026.

How many GILD shares has Andrew Dickinson sold recently under Rule 144?

Over the past three months, Andrew Dickinson has sold 6,000 GILD common shares. He sold 3,000 shares on December 15, 2025 for $366,000, and another 3,000 shares on January 15, 2026 for $372,930, according to the disclosure.

How were the GILD shares in the new Form 144 acquired?

The 3,000 GILD common shares covered by the new Form 144 were acquired as performance shares from the issuer on January 24, 2023. The filing notes the acquisition as a performance-based award, with payment described as “Not Applicable” in the consideration section.

Which broker is handling the proposed GILD share sale in this Form 144?

The proposed sale of 3,000 GILD common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to be sold on NASDAQ.

What is the aggregate market value of the GILD shares in the latest Form 144?

The 3,000 GILD common shares covered by the latest Form 144 have an indicated aggregate market value of $463,290. This figure reflects the value used in the notice for the proposed sale on NASDAQ through Morgan Stanley Smith Barney Executive Financial Services.

What representation does the insider make in the GILD Form 144 notice?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse, non-public information about GILD’s current or prospective operations, as required under Rule 144, when relying on a written trading plan or instructions.